Drug Res (Stuttg) 2017; 67(11): e1
DOI: 10.1055/s-0043-123671
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Correction: Iron Pharmacokinetics in Women with Iron Deficiency Anaemia Following A Single Oral Dose of a Novel Formulation of Tardyferon (Prolonged Release Ferrous Sulphate)

Andrew Leary
1   Department of Pharmacology & Therapeutics, University College Cork, Ireland
,
Laurence Barthe
2   Pierre Fabre Médicament, Boulogne, France
,
Thierry Clavel
2   Pierre Fabre Médicament, Boulogne, France
,
Claudie Sanchez
2   Pierre Fabre Médicament, Boulogne, France
,
Zahida Issiakhem
2   Pierre Fabre Médicament, Boulogne, France
,
Bruno Paillard
2   Pierre Fabre Médicament, Boulogne, France
,
Jean-Marc Edmond
2   Pierre Fabre Médicament, Boulogne, France
› Author Affiliations
Further Information

Publication History

Publication Date:
05 December 2017 (online)

Erratum

In Leary A, Barthe L, Clavel T et al. Iron Pharmacokinetics in Women with Iron Deficiency Anaemia Following A Single Oral Dose of a Novel Formulation of Tardyferon (Prolonged Release Ferrous Sulphate)

DOI http://dx.doi.org/10.1055/s-0043-113636

Drug Res 2017; 67: 647–652

Table 2 contained typesetting errors. The correct version is printed below.

Table 2 Pharmacokinetic parameters of serum iron following a single 160 mg oral dose of Tardyferon® in women with iron deficiency anaemia.

Parameters

n=30

CT0 (µg/L)

243 (161)

[56–726]

66

Cmax (µg/L)

3 195 (822)

[1 620–4 580]

26

C8h (µg/L)

2617 (990)

[391–3 910]

38

C12h (µg/L)

1 768 (1 058)

[112–3 407]

60

Tmax (h)

4

[2–6]

AUC0 -24 (h*µg/L)

40 242 (16 264)

[11 454–65 906]

40

Data are presented as mean (SD), [range] and CV% except for Tmax: median, [range]